- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01262521
Dietary Nitrate and Cardiovascular Health
Physiological Effects of Oral Nitrate on Vascular Function
An expanding number of studies suggest a therapeutic role for nitrate and nitrite, most notably in treatment and prevention of cardiovascular disease including ischemia-reperfusion (IR) injury and hypertension. The nutritional aspects of these cardioprotective effects are particularly intriguing since nitrate and nitrite are abundant in our everyday diet.
Whether increasing the circulating pool of nitric oxide and nitrite by dietary nitrate offers a novel mechanistic approach to regulate mobilization of circulating angiogenic cells and thus regenerative processes in cardiovascular medicine is not known. Thus, in the present study, we tested whether oral application of nitrate leads to an enhanced number of circulating angiogenic cells and whether this is associated with an improvement in endothelial function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Administration of a single dose of nitrate intervention or water alone to healthy volunteers. Before and up to 4 hours (short-term)/6 days (long-term) after ingestion, marker of vascular function are measured in plasma and by using high-resolution ultrasound.
Measurements are taken before and up to 4 h after double blind cross-over per os administration of a single dose of nitrate intervention (150 ml tab water with 150 umol/kg sodium-nitrate) or water control (100 ml Chapelle mineral water) to healthy volunteers. Circulating angiogenic cells are measured as CD34+/KDR+ and CD133+/KDR+ mononuclear cells in blood by flow cytometry and plasma is analyzed for nitrate and nitrite, as well as mobilization markers and cytokines including stromal cell derived factor, vascular endothelial growth factor and stem cell factor. All measurements are performed after >12h overnight fasting.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
NRW
-
Duesseldorf, NRW, Germany, 40225
- Heinrich-Heine-University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age > 20 years
- refrain from nitrate containing food ingestion during trial
Exclusion Criteria:
- > 36 years
- poor endothelial function
- acute infection
- any chronic heart or pulmonary disease
- arrhythmias
- acute or chronic renal failure
- cardio-vascular risk factors: diabetes mellitus, hypertension, hyperlipidemia
- intake of nutrition supplements (l-arginine, creatinine)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary nitrate
150 ml tab water with 150 umol/kg sodium-nitrate
|
150 ml tab water with 150 umol/kg sodium-nitrate
Other Names:
|
Placebo Comparator: Water
150 ml Chapelle mineral water
|
150 ml Chapelle mineral water
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Circulating angiogenic cells
Time Frame: 4 hours
|
4 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cytokines
Time Frame: 4 hours
|
4 hours
|
Endothelial function
Time Frame: 4 hours
|
4 hours
|
Collaborators and Investigators
Investigators
- Study Director: Malte Kelm, MD, PhD, University of Duesseldorf
- Study Chair: Tienush Rassaf, MD, PhD, University of Duesseldorf
- Principal Investigator: Christian Meyer, MD, University of Duesseldorf
- Principal Investigator: Christian Heiss, MD, University of Duesseldorf
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Protective dietary nitrate
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on no Medications
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedHigh-risk MedicationsUnited States
-
Hospices Civils de LyonCompletedPotentially Inappropriate MedicationsFrance
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Català de la Salut; University Rovira i VirgiliRecruitingPolypharmacy | Potentially Inappropriate MedicationsSpain
-
VA Boston Healthcare SystemOregonCompletedUse of Sleep MedicationsUnited States
-
Icahn School of Medicine at Mount SinaiNYC Health + HospitalsCompletedPotentially Inappropriate MedicationsUnited States
-
Geriatric Education and Research InstituteTan Tock Seng Hospital; Changi General HospitalCompletedMultimorbidity | Polypharmacy | Potentially Inappropriate MedicationsSingapore
-
Brooke Army Medical CenterCompletedSubjects' Understanding of Prescribed MedicationsUnited States
-
Centre de recherche du Centre hospitalier universitaire...RecruitingPhysical Function | Deprescribing Anticholinergic and Sedative MedicationsCanada
-
University of FloridaNational Human Genome Research Institute (NHGRI)RecruitingPharmacogenetic Testing | Use of Prescription MedicationsUnited States
-
Boston Children's HospitalTerminatedSafety and Efficacy of Sedation MedicationsUnited States
Clinical Trials on Dietary nitrate
-
University of VirginiaCompletedArterial Stiffness | Vascular DilationUnited States
-
Nanyang Technological UniversityRecruitingExercise PerformanceSingapore
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Preserved Ejection Fraction | Pulmonary; HypertensionUnited States
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedHypertension
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedChronic Obstructive Pulmonary DiseaseIreland
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedCardiomyopathy
-
University Hospital, EssenUnknown
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
University of VirginiaRecruitingPeripheral Arterial Disease | Peripheral Vascular DiseasesUnited States
-
Maastricht University Medical CenterUnknownType 2 Diabetes MellitusNetherlands